Top of page Skip navigation

    Register today...


    Join us for some great networking

Our thanks to the following organisations for supporting this  year's UK Bioscience Forum



BBSRC invests in world-class bioscience research and training on behalf of the UK public. Our aim is to further scientific knowledge, to promote economic growth, wealth and job creation and to improve quality of life in the UK and beyond.

Funded by Government, BBSRC invested over £469 million in world-class bioscience in 2016 - 2017. We support research and training in universities and strategically funded institutes. BBSRC research and the people we fund are helping society to meet major challenges, including food security, green energy and healthier, longer lives. Our investments underpin important UK economic sectors, such as farming, food, industrial biotechnology and pharmaceuticals.

More information about BBSRC, our science and our impact
More information about BBSRC strategically funded institutes

Hammersmith Medicines Research (HMR) is a clinical research organisation (CRO) specialising in phase 1 and early phase 2 studies.  We’ve done more than 800 trials – almost all conceivable types, many of them first administration to humans.  We have:  new premises with 145 beds; 240 staff; MHRA GCP and GMP approval; laboratory and pharmacy accreditation; and ISO9001 quality system.

Trio Medicines is a wholly-owned subsidiary of HMR, with a portfolio of three compounds at different stages of development, and a BIA member.



Miltenyi Biotec is a global provider of products and services that advance biomedical research and cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. Used by scientists and clinicians around the world, our technologies cover techniques of sample preparation, cell isolation, cell sorting, flow cytometry, and cell culture.

Our 25 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer. Today, Miltenyi Biotec has more than 1,400 employees in 25 countries – all dedicated to helping researchers and clinicians make a greater impact on science and health.



Potter Clarkson


Potter Clarkson LLP is an award-winning, top-tier firm of European patent and trade mark attorneys and IP solicitors, and is not only one of the largest full service Intellectual Property practices in Europe, but also operates one of the largest Life Sciences departments as well.

Employing some 60 qualified professionals and 90 paralegals, administrators and support staff at their Nottingham office, Potter Clarkson offers clients unrivalled expertise in helping them protect their innovations.

Well known for handling some of the most complex and challenging patent and trade mark cases for clients around the globe across a wide variety of sectors (in particular the Life Sciences sector), they are particularly well-regarded for their successful prosecution, opposition and appeal work.

Potter Clarkson’s ability to offer the full range of litigation services (including contentious, non-contentious and commercial legal services) makes it the European firm of choice for several global giants, household names, universities and a range of smaller companies and individuals.



Public Health England is an executive agency of the Department of Health, and a distinct delivery organisation with operational autonomy to advise and support government, local authorities and the NHS in a professionally independent manner.  With 5,500 staff PHE is responsible for protecting and improving the nation’s health and wellbeing and reducing inequalities.  Our translational research, development and testing programmes focus on diagnostics, vaccines and other interventions across healthcare and public health.  Public Health England was established on 1 April 2013 to bring together public health specialists from more than 70 organisations into a single public health service.

Stratagem IPM

Stratagem Intellectual Property Management Ltd is a full-service, Cambridge UK-based, out sourced intellectual organisation and management company with global reach.


Stratagem IPM Ltd fills a developing need within industry for the provision of strategic advice and intellectual property management for life science, medtech, cleantech and high technology companies.  Stratagem’s qualified patent and trade mark attorneys use a commercial perspective and hands on management approach to enhance the value of IP assets.